Ligand validation:3AS0

SAU: 13-methyl[1,3]benzodioxolo[5,6-c][1,3]dioxolo[4,5-i]phenanthridin-13-ium

SAU is a Ligand Of Interest in 3AS0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3AS0_SAU_A_607	13%	13%	0.271	0.812	1.32	2.57	6	15	1	0	100%	1
3AS0_SAU_A_606	5%	24%	0.284	0.692	1.41	1.69	5	9	0	0	100%	1
3ARV_SAU_A_606	53%	13%	0.117	0.876	1.7	2.26	6	15	0	0	100%	1
5ZBZ_SAU_A_301	59%	9%	0.127	0.909	1.44	2.94	4	16	10	0	100%	1
7C6Q_SAU_A_501	40%	9%	0.208	0.918	2.34	2.06	13	11	12	0	100%	0.8
5ICF_SAU_A_402	20%	6%	0.218	0.818	2.48	2.69	9	12	8	0	100%	0.8
3NX5_SAU_C_7	10%	10%	0.274	0.772	2.41	1.93	8	12	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.